Could a common diabetes drug protect the brain in Huntington's?

NCT ID NCT04826692

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether metformin, a widely used diabetes drug, can slow the loss of thinking skills in people with Huntington's disease. Sixty adults took either metformin or a placebo for one year. Researchers measured changes in memory, attention, and other cognitive functions using standard tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
metformin
What this could lead to
If it works, metformin could offer a safe, affordable way to slow cognitive decline in Huntington's disease.
What could go wrong
This is a small, early-phase trial. Metformin is not a cure, and it may not improve thinking or memory. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Complejo Hospitalario de Albacete

    Albacete, Castille-La Mancha, 02006, Spain

  • Hospital General Universitario Dr. Balmis

    Alicante, Alicante, 03010, Spain

  • Hospital General Universitario de Elche

    Elche, Alicante, 03203, Spain

  • Hospital Universitari Son Espases

    Palma de Mallorca, Balearic Islands, 07120, Spain

  • Hospital Universitario Burgos

    Burgos, Castille and León, 09006, Spain

  • Hospital Universitario Central de Asturias

    Oviedo, Principality of Asturias, 33011, Spain

  • Hospital Universitario Mare de Déu de la Mercé

    Barcelona, Barcelona, 08035, Spain

  • Hospital Universitario Ramón y Cajal

    Madrid, Madrid, 28034, Spain

  • Hospital Universitario y Politécnico La Fe

    Valencia, València, 46026, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.